3-Hydroxycarboplatin, a Simple Carboplatin Derivative Endowed with an Improved Toxicological Profile | |
Liu, Weiping1; Chen, Xizhu1; Ye, Qingsong1; Hou, Shuqian1; Lou, Liguang2; Xie, Chengying2 | |
刊名 | PLATINUM METALS REVIEW |
2012-10 | |
卷号 | 56期号:4页码:248-256 |
ISSN号 | 0032-1400 |
DOI | 10.1595/147106712X654204 |
文献子类 | Article |
英文摘要 | 3-Hydroxycarboplatin, a simple carboplatin derivative, was synthesised using a novel method, characterised and evaluated for its anticancer activity in vitro and in vivo. It shows comparable antitumour activity to that of carboplatin but has much lower toxicity particularly with respect to myelosuppression, revealing great potential for development as a new antitumour platinum drug to replace carboplatin. |
资助项目 | National Science Foundation of P. R. China[21161010] ; China National Research and Development (RD) Program[2012BAE06B08] |
WOS关键词 | PLATINUM(II) COMPLEXES ; SALICYLATE DERIVATIVES ; ANTICANCER ACTIVITY ; ANTITUMOR-ACTIVITY ; CANCER ; ANALOG |
WOS研究方向 | Chemistry |
语种 | 英语 |
出版者 | JOHNSON MATTHEY PUBL LTD CO |
WOS记录号 | WOS:000313558800006 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/277914] |
专题 | 药理学第一研究室 |
通讯作者 | Liu, Weiping |
作者单位 | 1.Kunming Inst Precious Met, State Key Lab Adv Technol Comprehens Utilizat Pla, Kunming 650106, Yunnan, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Liu, Weiping,Chen, Xizhu,Ye, Qingsong,et al. 3-Hydroxycarboplatin, a Simple Carboplatin Derivative Endowed with an Improved Toxicological Profile[J]. PLATINUM METALS REVIEW,2012,56(4):248-256. |
APA | Liu, Weiping,Chen, Xizhu,Ye, Qingsong,Hou, Shuqian,Lou, Liguang,&Xie, Chengying.(2012).3-Hydroxycarboplatin, a Simple Carboplatin Derivative Endowed with an Improved Toxicological Profile.PLATINUM METALS REVIEW,56(4),248-256. |
MLA | Liu, Weiping,et al."3-Hydroxycarboplatin, a Simple Carboplatin Derivative Endowed with an Improved Toxicological Profile".PLATINUM METALS REVIEW 56.4(2012):248-256. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论